Removal of background autofluorescence on the IVIS™ optical imaging system using the spectral unmixing algorithm in Living Image™ software improves both visualization and quantification of tumor cells expressing TdTomato fluorescent protein.

Example of multiplexing 4 simultaneous fluorescent readouts using the spectral unmixing algorithm in Living Image™ software.

Bioluminescence tomography of IVISbrite™ 4T1 tumor (s.c.) imaged on the IVIS™ Spectrum 2 optical imaging system.

Simultaneous 5 mice bioluminescent, fluorescent, and x-ray imaging of tumors injected into mouse knee. IVISbrite™ 4T1 Red F-luc tumor cell line injected subcutaneously in flank and imaged on IVIS™ Lumina X5: (top) fluorescence detection of IVISense™ Integrin Receptor 750 probe accumulation at tumor site, (middle) bioluminescent signal acquisition, and (bottom) five mouse X-ray overlaid with bioluminescent signal from knee.

High-throughput simultaneous imaging of 10 mice on the IVIS™ Spectrum 2 optical imaging system using optional manifold.

Carrageenan-induced paw inflammation in right hindpaw of BALB/c mouse, imaged with IVISense™ Vascular 680 fluorescent probe.

2D and 3D fluorescence imaging of mammary fat pad tumors using IVISense™ Pan Cathepsin fluorescent probe. Imaged on the IVIS™ SpectrumCT system.

Fluorescence imaging using the IVIS™ Spectrum system of liver inflammation during the early stages of NASH in mice on a high fat diet (HFD). Mice received i.v. cocktail injection of IVISense™ Annexin-V 750, IVISense MMP 750, & IVISense Transferrin Receptor 750 (AMT750) fluorescent probes to detect cell death, inflammation, and iron metabolism changes in the body. IVISense Vascular 680 (IV680) was also used to study vascular leakiness in inflamed tissues. Fluorescent imaging signals were measured and quantified 24 hours after probe injection.

Bioluminescence kinetic analysis of five mice bearing subcutaneous tumors. Twenty consecutive images were taken automatically using Living Image™ software.

High-resolution x-ray imaging of kidneys using the IVIS™ Lumina X5 system.

Comparison of 2D vs. 3D bioluminescence imaging of HCT-116 tumor metastasis. Imaged using the IVIS™ SpectrumCT system.

Comparison CT image scans of a Control (left) and OVEX (right) mouse femur using the Quantum™ GX3 microCT. Considerable trabecular loss, and a thinner growth plate can be seen in the OVEX mouse bone.

(Left) Mouse jaw scanned on the Quantum™ GX3 microCT, showing molars and age-related bone loss in the gum-bed. (Right) Quantum™ GX3 microCT imaging of mouse ear showing inner ear bones.

Contrast-enhanced whole-body stitched scan taken on the Quantum™ GX3 microCT. Bone and contrast are shown in yellow and adipose tissue is shown in red.

Lizard embryos. Imaged on the Quantum™ GX2 microCT system.

Ex vivo imaging of mouse lung lobe using the Quantum™ GX3 microCT system at FOV 8 mm.

Longitudinal imaging of mouse lung tumors using the Quantum™ microCT respiratory gated scan function. Over time, the healthy lung tissue volume (shown in orange) decreases as the lungs become infiltrated with tumor and immune cells.

MicroCT image on the Quantum™ GX2 system of a mouse brain infused with vascular casting agent showing blood vessels in the brain.

Axial slice from a microCT image of a mouse lung. A retrospective respiratory-gated scan was performed on the Quantum™ GX2 microCT system to remove breathing motion artifacts.

Contrast-enhanced microCT image of a mouse. Digital threshold-based segmentation shows the bone (tan), vasculature (red), and lung (blue). The image was taken on a Quantum™ GX2 instrument.

Vega™ ultrasound imaging shows the efficacy of a vascular disrupting agent for tumor treatment. The tumor volume is shown in blue (B-mode) and vasculature is shown in yellow (acoustic angiography using VesselVue™ microbubble contrast agent).

Whole-body ultrasound imaging of a mouse using the Vega Preclinical Ultrasound instrument. The widefield imaging capabilities of the Vega system shows tumor and detailed anatomy.

Abdominal widefield imaging scan and segmented volume of a subcutaneous tumor using the Vega™ system and SonoEQ™ software. (Top) Mouse prone body position. (Bottom) supine body position.

Longitudinal ultrasound imaging using the Vega™ system of CDAHFD mouse model used to induce NASH. Axial (left top row) and coronal (left bottom row) imaging in B-Mode showing liver brightness and enlargement over time (green dash). (Right) Shear wave elastography (SWE) colormap overlay showing an increase in liver stiffness at 2 months.

Targeted injection of VesselVue™ microbubble contrast agent into the ventricle of mouse heart using the VivoJect™ image-guided injection accessory couple with the Vega™ ultrasound system.

Fluorescence and x-ray imaging using the IVIS™ Lumina X5 system. IVISbrite™ 4T1 Red F-luc tumor cells implanted in right knee  of nu/nu mouse  and imaged with Pan Cathepsin 750 fluorescent probe.

Multimodal imaging showing co-registration of 3D bioluminescence imaging (BLI) using the IVIS™ Spectrum 2 and microCT using the Quantum™ GX3. The 3D BLI shows the primary tumor and the microCT shows skeletal anatomy.

MicroCT alone (left) overlaid with fluorescence tomography (right) of mouse kidneys. Iodonated contrast agent highlights the kidneys in the CT image and IVISense™ Folate Receptor fluorescent probe is shown accumulating in the kidneys in the fluorescence image. Image was taken on the IVIS™ SpectrumCT instrument.

Ovariectomized SKH1-E mouse imaged by x-ray alone (left) and combined x-ray and IVISense™ Osteo 680 fluorescent probe (right) showing high bone turnover in spine, and normal turnover in knee, and foot. Imaged using thw IVIS™ Lumina X5 optical system with integrated x-ray.

Longitudinal study tracking tumor metastasis progression over 28 days. Imaged on the IVIS™ Spectrum system. Co-registration imaging using the IVIS Spectrum optical and Quantum GX2 microCT systems.